Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. EFFECT Other Notice of Effectiveness
  2. UPLOAD Other SEC-generated Letter
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. SC 13D/A Stake Beneficial Ownership Report
  5. SC 13D/A Stake Beneficial Ownership Report
  6. S-3 Offering Registration Statement
  7. 8-K Event Other events
  8. SC 13D Stake Beneficial Ownership Report
  9. SC 13D Stake Beneficial Ownership Report
  10. 10-Q Report Quarterly Report
  11. 8-K/A Event Exhibits
  12. 8-K Event Results of operations
  13. 4 Grant or award Director acquired 101,606 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 161,116 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 786 shares (grant or award)
  18. SC 13D Stake Beneficial Ownership Report
  19. 8-K/A Event Executive or director change
  20. SC 13D Stake Beneficial Ownership Report

Page 21 of 38 · 753 filings